Natural Health Trends Corp Accepts Director Resignation

Natural Health Trends Corp disclosed the resignation of a board member in an 8-K filed with the SEC on May 7 2026.

The filing covers three items: departure or election of directors or principal officers under Item 5.02, submission of matters to a vote of security holders under Item 5.07, and financial statements and exhibits under Item 9.01. Natural Health Trends Corp, ticker NHTC and CIK 0000912061, is a publicly traded company whose shares trade over the counter.

The Item 5.02 section identifies the named director who resigned, states the effective date of May 4 2026, and notes that the board accepted the resignation. The filing does not cite a cause for the departure. Prior to the change the board maintained its full complement of directors; the new state reduces that number by one until the company either fills the vacancy through election of a replacement or operates with the reduced board.

The resignation takes effect immediately on the stated date.

The departure initiates several operational requirements. The company must ensure compliance with Nasdaq or applicable exchange listing standards on board independence and committee composition if the departing director served on the audit, compensation or nominating committees.

A separate Form 8-K or proxy statement amendment will be required if the company later elects a new director. Shareholders who voted at the meeting covered under Item 5.07 will see the board size reflected in future proxy materials, and the company must update its governance disclosures within the deadlines set by SEC rules for current reports.

This filing constitutes the second Item 5.02 disclosure by Natural Health Trends Corp in the past 24 months. The company last reported a board-level change in 2024. The current 8-K also includes exhibits that document the resignation letter and any related board resolutions, which become part of the permanent SEC record.

The resignation does not alter the company's executive officer roster, as the departing individual held only a director position and not a principal officer role such as chief executive or chief financial officer. No immediate impact on day-to-day operations is stated in the filing.